Masoud Najafi

16.3k total citations · 7 hit papers
207 papers, 12.9k citations indexed

About

Masoud Najafi is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Masoud Najafi has authored 207 papers receiving a total of 12.9k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Molecular Biology, 72 papers in Radiology, Nuclear Medicine and Imaging and 42 papers in Oncology. Recurrent topics in Masoud Najafi's work include Effects of Radiation Exposure (62 papers), Curcumin's Biomedical Applications (19 papers) and Circadian rhythm and melatonin (17 papers). Masoud Najafi is often cited by papers focused on Effects of Radiation Exposure (62 papers), Curcumin's Biomedical Applications (19 papers) and Circadian rhythm and melatonin (17 papers). Masoud Najafi collaborates with scholars based in Iran, Iraq and Türkiye. Masoud Najafi's co-authors include Keywan Mortezaee, Bagher Farhood, Ahmed Eleojo Musa, Milad Ashrafizadeh, Nasser Hashemi Goradel, Dheyauldeen Shabeeb, Jamal Majidpoor, Ali Zarrabi, Abolhasan Rezaeyan and Amirhossein Ahmadi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cellular and Molecular Life Sciences and Archives of Biochemistry and Biophysics.

In The Last Decade

Masoud Najafi

204 papers receiving 12.8k citations

Hit Papers

CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A r... 2018 2026 2020 2023 2018 2018 2018 2018 2018 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
    2018 1.2k citations Bagher Farhood, Masoud Najafi et al. Journal of Cellular Physiology profile →
  2. Cyclooxygenase‐2 in cancer: A review
    2018 588 citations Masoud Najafi, Bagher Farhood et al. Journal of Cellular Physiology profile →
  3. Extracellular matrix (ECM) stiffness and degradation as cancer drivers
    2018 520 citations Masoud Najafi, Bagher Farhood et al. profile →
  4. Cancer stem cells (CSCs) in cancer progression and therapy
    2018 426 citations Masoud Najafi, Bagher Farhood et al. Journal of Cellular Physiology profile →
  5. Macrophage polarity in cancer: A review
    2018 378 citations Masoud Najafi, Bagher Farhood et al. profile →
  6. Cancer stem cell (CSC) resistance drivers
    2019 334 citations Masoud Najafi et al. profile →
  7. Mechanisms of cancer cell death induction by paclitaxel: an updated review
    2022 119 citations Masoud Najafi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masoud Najafi Iran 65 5.4k 3.5k 2.4k 2.2k 1.8k 207 12.9k
Bagher Farhood Iran 53 3.5k 0.6× 2.7k 0.8× 1.4k 0.6× 1.7k 0.8× 1.8k 1.0× 189 9.7k
Keywan Mortezaee Iran 51 4.0k 0.7× 3.6k 1.0× 1.8k 0.7× 2.6k 1.2× 1.2k 0.6× 143 9.7k
Michele Caraglia Italy 65 7.4k 1.4× 5.0k 1.4× 3.2k 1.3× 1.5k 0.7× 2.1k 1.1× 488 16.0k
Lee Jia China 56 5.2k 1.0× 3.4k 1.0× 1.1k 0.5× 2.4k 1.1× 868 0.5× 311 13.2k
Mingyao Liu China 70 10.2k 1.9× 3.2k 0.9× 2.0k 0.8× 1.9k 0.8× 1.0k 0.6× 424 17.2k
Canhua Huang China 66 7.3k 1.4× 2.2k 0.6× 2.8k 1.2× 2.2k 1.0× 1.3k 0.7× 225 13.7k
B. Mark Evers United States 73 10.5k 1.9× 4.3k 1.2× 3.5k 1.4× 1.6k 0.7× 1.2k 0.7× 362 17.6k
Aamir Ahmad United States 66 7.8k 1.4× 3.8k 1.1× 3.9k 1.6× 818 0.4× 969 0.5× 254 13.8k
Jack L. Arbiser United States 62 5.6k 1.0× 2.3k 0.6× 1.5k 0.6× 1.7k 0.8× 1.0k 0.5× 246 12.6k
Athanasios G. Papavassiliou Greece 68 8.0k 1.5× 3.2k 0.9× 2.7k 1.1× 1.6k 0.7× 1.3k 0.7× 488 17.5k

Countries citing papers authored by Masoud Najafi

Since Specialization
Citations

This map shows the geographic impact of Masoud Najafi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masoud Najafi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masoud Najafi more than expected).

Fields of papers citing papers by Masoud Najafi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masoud Najafi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masoud Najafi. The network helps show where Masoud Najafi may publish in the future.

Co-authorship network of co-authors of Masoud Najafi

This figure shows the co-authorship network connecting the top 25 collaborators of Masoud Najafi. A scholar is included among the top collaborators of Masoud Najafi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masoud Najafi. Masoud Najafi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moradi, Hadi, et al.. (2023). Evaluating the Necessity and Radiation Risk of Brain CT Scans Requested by the Trauma Emergency Department. Journal of Biomedical Physics and Engineering. 13(6). 515–522. 2 indexed citations
2.
Ashrafizadeh, Milad, et al.. (2021). Anti-Inflammatory Activity of Melatonin: a Focus on the Role of NLRP3 Inflammasome. Inflammation. 44(4). 1207–1222. 45 indexed citations
3.
Najafi, Masoud, et al.. (2020). Curcumin Protects Against Radiotherapy-Induced Oxidative Injury to the Skin. SHILAP Revista de lepidopterología. 2 indexed citations
4.
Ashrafizadeh, Milad, Kiavash Hushmandi, Mehrdad Hashemi, et al.. (2020). Role of microRNA/Epithelial-to-Mesenchymal Transition Axis in the Metastasis of Bladder Cancer. Biomolecules. 10(8). 1159–1159. 99 indexed citations
5.
Ashrafizadeh, Milad, Ali Zarrabi, Kiavash Hushmandi, et al.. (2020). Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy. ACS Combinatorial Science. 22(12). 669–700. 79 indexed citations
6.
Ashrafizadeh, Milad, et al.. (2020). Recent advances and future directions in anti‐tumor activity of cryptotanshinone: A mechanistic review. Phytotherapy Research. 35(1). 155–179. 33 indexed citations
7.
Ashrafizadeh, Milad, Masoud Najafi, Pooyan Makvandi, et al.. (2020). Versatile role of curcumin and its derivatives in lung cancer therapy. Journal of Cellular Physiology. 235(12). 9241–9268. 119 indexed citations
8.
Ashrafizadeh, Milad, Kiavash Hushmandi, Ebrahim Rahmani Moghadam, et al.. (2020). C-Myc Signaling Pathway in Treatment and Prevention of Brain Tumors. Current Cancer Drug Targets. 21(1). 2–20. 23 indexed citations
9.
Ashrafizadeh, Milad, Hui Li Ang, Ebrahim Rahmani Moghadam, et al.. (2020). MicroRNAs and Their Influence on the ZEB Family: Mechanistic Aspects and Therapeutic Applications in Cancer Therapy. Biomolecules. 10(7). 1040–1040. 72 indexed citations
10.
Ashrafizadeh, Milad, Ali Zarrabi, Farid Hashemi, et al.. (2020). Nobiletin in Cancer Therapy: How This Plant Derived-Natural Compound Targets Various Oncogene and Onco-Suppressor Pathways. Biomedicines. 8(5). 110–110. 69 indexed citations
11.
Ashrafizadeh, Milad, Ali Zarrabi, Sima Orouei, et al.. (2020). STAT3 Pathway in Gastric Cancer: Signaling, Therapeutic Targeting and Future Prospects. Biology. 9(6). 126–126. 87 indexed citations
12.
Ashrafizadeh, Milad, Masoud Najafi, Sima Orouei, et al.. (2020). Resveratrol Modulates Transforming Growth Factor-Beta (TGF-β) Signaling Pathway for Disease Therapy: A New Insight into Its Pharmacological Activities. Biomedicines. 8(8). 261–261. 48 indexed citations
13.
Ashrafizadeh, Milad, Masoud Najafi, Hui Li Ang, et al.. (2020). PTEN, a Barrier for Proliferation and Metastasis of Gastric Cancer Cells: From Molecular Pathways to Targeting and Regulation. Biomedicines. 8(8). 264–264. 62 indexed citations
14.
Ashrafizadeh, Milad, Kiavash Hushmandi, Ebrahim Rahmani Moghadam, et al.. (2020). Progress in Delivery of siRNA-Based Therapeutics Employing Nano-Vehicles for Treatment of Prostate Cancer. Bioengineering. 7(3). 91–91. 81 indexed citations
15.
Ashrafizadeh, Milad, Masoud Najafi, Reza Mohammadinejad, Tahereh Farkhondeh, & Saeed Samarghandian. (2020). Flaming the fight against cancer cells: the role of microRNA-93. Cancer Cell International. 20(1). 277–277. 12 indexed citations
16.
Koklesová, Lenka, Alena Líšková, Marek Samec, et al.. (2020). Carotenoids in Cancer Metastasis—Status Quo and Outlook. Biomolecules. 10(12). 1653–1653. 40 indexed citations
17.
Najafi, Masoud, Shima Tavakol, Ali Zarrabi, & Milad Ashrafizadeh. (2020). Dual role of quercetin in enhancing the efficacy of cisplatin in chemotherapy and protection against its side effects: a review. Archives of Physiology and Biochemistry. 128(6). 1438–1452. 53 indexed citations
18.
Samadian, Hadi, Mehdi Jaymand, Asaad Azarnezhad, et al.. (2020). Genotoxicity assessment of carbon-based nanomaterials; Have their unique physicochemical properties made them double-edged swords?. Mutation Research/Reviews in Mutation Research. 783. 108296–108296. 94 indexed citations
19.
Najafi, Masoud, et al.. (2018). Radiation-induced Non-targeted Effect and Carcinogenesis; Implications in Clinical Radiotherapy. Journal of Biomedical Physics and Engineering. 8(4Dec). 7 indexed citations
20.
Yahyapour, Rasoul, Peyman Amini, Hana Saffar, et al.. (2018). Metformin Protects Against Radiation-Induced Heart Injury and Attenuates the Upregulation of Dual Oxidase Genes Following Rat's Chest Irradiation.. PubMed Central. 7(3). 193–202. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bagher Farhood Breakdown of academic impact, for papers by Keywan Mortezaee Breakdown of academic impact, for papers by Michele Caraglia Breakdown of academic impact, for papers by Lee Jia Breakdown of academic impact, for papers by Mingyao Liu Breakdown of academic impact, for papers by Canhua Huang Breakdown of academic impact, for papers by B. Mark Evers Breakdown of academic impact, for papers by Aamir Ahmad Breakdown of academic impact, for papers by Jack L. Arbiser Breakdown of academic impact, for papers by Athanasios G. Papavassiliou
Rankless by CCL
2026